Cargando…
A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor
Vectors that facilitate the engineering of T cells that can better harness endogenous immunity and overcome suppressive barriers in the tumour microenvironment would help improve the safety and efficacy of T-cell therapies for more patients. Here we report the design, production and applicability, i...
Autores principales: | Reichenbach, Patrick, Giordano Attianese, Greta Maria Paola, Ouchen, Khaoula, Cribioli, Elisabetta, Triboulet, Melanie, Ash, Sarah, Saillard, Margaux, Vuillefroy de Silly, Romain, Coukos, George, Irving, Melita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504085/ https://www.ncbi.nlm.nih.gov/pubmed/37069267 http://dx.doi.org/10.1038/s41551-023-01013-5 |
Ejemplares similares
-
Enforcing GLUT3 expression in CD8(+) T cells improves fitness and tumor control by promoting glucose uptake and energy storage
por: Cribioli, Elisabetta, et al.
Publicado: (2022) -
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
por: Cribioli, Elisabetta, et al.
Publicado: (2022) -
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
por: Irving, Melita, et al.
Publicado: (2017) -
VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding
por: Lanitis, Evripidis, et al.
Publicado: (2021) -
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
por: Biagi, Ettore, et al.
Publicado: (2011)